Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Feb 20, 2015 brown michael s Director Sell 1,000 422.72
Feb 20, 2015 brown michael s Director Option Execute 1,000 57.11
Feb 20, 2015 goldstein joseph l Director Sell 5,000 423.61 - 424.14
Feb 20, 2015 goldstein joseph l Director Option Execute 5,000 177.82
Feb 20, 2015 ryan arthur f Director Sell 29,250 421.72 - 424.58
Feb 20, 2015 ryan arthur f Director Option Execute 29,250 33.42 - 273.67
Feb 20, 2015 sing george l Director Sell 15,000 423.12
Feb 20, 2015 sing george l Director Option Execute 15,000 18.61
Feb 20, 2015 van plew daniel p Officer Disposition (Non Open Market) 10,569 424.70
Feb 20, 2015 van plew daniel p Officer Option Execute 20,000 21.25
Feb 17, 2015 aberman michael s Officer Automatic Sell 3,692 401.54 - 406.24
Feb 13, 2015 aberman michael s Officer Automatic Sell 3,808 402.05
Feb 13, 2015 aberman michael s Officer Option Execute 7,500 24.00
Jan 2, 2015 powchik peter Officer Automatic Sell 10,822 410.99 - 418.40
Jan 2, 2015 schleifer leonard s Officer Automatic Buy 1,500 n/a
Jan 2, 2015 schleifer leonard s Officer Automatic Sell 1,500 408.64 - 416.00
Dec 31, 2014 powchik peter Officer Automatic Sell 14,178 412.78
Dec 31, 2014 powchik peter Officer Option Execute 25,000 52.03
Dec 24, 2014 sanofi Beneficial Owner (10% or more) Buy 30,002 392.72 - 399.74
Dec 23, 2014 sanofi Beneficial Owner (10% or more) Buy 171,457 384.43 - 398.16
Showing 41-60 of 950 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)